THMO - ThermoGenesis Holdings, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Rancho Cordova,
United States
Type: Equity
THMO price evolution
THMO
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.18 | $2 | $4.02 | $4.45 |
| Short term investments | ||||
| Net receivables | $1.15 | $0.95 | $0.37 | $0.77 |
| Inventory | $1.25 | $1.41 | $2.59 | $3.49 |
| Total current assets | $4.35 | $5.18 | $6.92 | $8.45 |
| Long term investments | ||||
| Property, plant & equipment | $5.48 | $5.8 | $5.93 | $6.02 |
| Goodwill & intangible assets | $2.04 | $2.05 | ||
| Total noncurrent assets | $5.74 | $6.05 | $9 | $9.16 |
| Total investments | ||||
| Total assets | $10.09 | $11.23 | $15.92 | $17.61 |
| Current liabilities | ||||
| Accounts payable | $1.41 | $1.58 | $0.82 | $1.02 |
| Deferred revenue | $1.04 | $0.8 | $1.5 | $1.74 |
| Short long term debt | $4.21 | $7.66 | $5.27 | $7.16 |
| Total current liabilities | $8.3 | $11.76 | $8.89 | $10.99 |
| Long term debt | $2.72 | $2.9 | $3.07 | $3.22 |
| Total noncurrent liabilities | $2.87 | $3.05 | $3.77 | $4 |
| Total debt | $6.93 | $10.56 | $8.34 | $10.38 |
| Total liabilities | $11.17 | $14.82 | $12.66 | $14.98 |
| Shareholders' equity | ||||
| Retained earnings | -$286.02 | -$284.17 | -$277.15 | -$273.54 |
| Other shareholder equity | $0.11 | $0.11 | $0.11 | $0.1 |
| Total shareholder equity | $0.97 | -$1.67 | $4.59 | $3.83 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2 | $4.18 | $7.28 | $7.16 |
| Short term investments | ||||
| Net receivables | $0.95 | $1.86 | $0.73 | $1.38 |
| Inventory | $1.41 | $4.34 | $7.08 | $7.1 |
| Total current assets | $5.18 | $10.88 | $14.96 | $15.3 |
| Long term investments | ||||
| Property, plant & equipment | $5.8 | $5.18 | $1.83 | $2.15 |
| Goodwill & intangible assets | $2.07 | $2.1 | $2.14 | |
| Total noncurrent assets | $6.05 | $8.5 | $5.69 | $5.56 |
| Total investments | ||||
| Total assets | $11.23 | $19.39 | $20.65 | $20.86 |
| Current liabilities | ||||
| Accounts payable | $1.58 | $2.31 | $3.51 | $3.45 |
| Deferred revenue | $0.8 | $1.69 | $1.96 | $2.2 |
| Short long term debt | $7.66 | $6.74 | $0.81 | $0.45 |
| Total current liabilities | $11.76 | $11.51 | $6.35 | $6.14 |
| Long term debt | $2.9 | $3.63 | $9.64 | $7.23 |
| Total noncurrent liabilities | $3.05 | $4.55 | $10.91 | $8.85 |
| Total debt | $10.56 | $10.37 | $10.46 | $7.68 |
| Total liabilities | $14.82 | $16.06 | $17.25 | $14.99 |
| Shareholders' equity | ||||
| Retained earnings | -$284.17 | -$266.19 | -$264.66 | -$253.28 |
| Other shareholder equity | $0.11 | $0.11 | $0.03 | $0.02 |
| Total shareholder equity | -$1.67 | $4.3 | $3.83 | $5.8 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.74 | $2.41 | $2.19 | $2.27 |
| Cost of revenue | $1.53 | $2.44 | $1.8 | $1.8 |
| Gross Profit | $1.2 | -$0.04 | $0.4 | $0.47 |
| Operating activities | ||||
| Research & development | $0.21 | $0.33 | $0.27 | $0.38 |
| Selling, general & administrative | $1.55 | $1.88 | $1.69 | $1.82 |
| Total operating expenses | $1.76 | $4.22 | $1.93 | $2.2 |
| Operating income | -$0.56 | -$4.26 | -$1.53 | -$1.73 |
| Income from continuing operations | ||||
| EBIT | -$0.4 | -$3.67 | -$1.5 | -$1.59 |
| Income tax expense | ||||
| Interest expense | $1.45 | $3.34 | $2.12 | $0.67 |
| Net income | ||||
| Net income | -$1.86 | -$7.01 | -$3.62 | -$2.26 |
| Income (for common shares) | -$1.86 | -$7.01 | -$3.62 | -$2.26 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9.45 | $10.48 | $9.29 | $9.74 |
| Cost of revenue | $7.51 | $7.77 | $5.8 | $8.48 |
| Gross Profit | $1.93 | $2.71 | $3.49 | $1.26 |
| Operating activities | ||||
| Research & development | $1.28 | $1.66 | $2.21 | $2.48 |
| Selling, general & administrative | $7.22 | $7.24 | $8.52 | $7.68 |
| Total operating expenses | $10.49 | $8.9 | $10.72 | $10.15 |
| Operating income | -$8.56 | -$6.19 | -$7.23 | -$8.89 |
| Income from continuing operations | ||||
| EBIT | -$7.94 | -$5.65 | -$5.28 | -$8.44 |
| Income tax expense | ||||
| Interest expense | $10.03 | $5.62 | $6.1 | $7.91 |
| Net income | ||||
| Net income | -$17.98 | -$11.27 | -$11.38 | -$16.35 |
| Income (for common shares) | -$17.98 | -$11.27 | -$11.38 | -$16.35 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$1.86 | -$7.01 | -$3.62 | -$2.26 |
| Operating activities | ||||
| Depreciation | $0.33 | $0.33 | $0.28 | $0.27 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.01 | $0.01 | $0.01 | $0.01 |
| Total cash flows from operations | -$0.51 | -$2.04 | -$0.25 | -$0.81 |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.19 | -$0.18 | -$0.59 |
| Investments | ||||
| Total cash flows from investing | -$0.02 | -$0.19 | -$0.18 | -$0.59 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.1 | -$0.2 | ||
| Net borrowings | -$0.4 | |||
| Total cash flows from financing | -$0.3 | $0.22 | ||
| Effect of exchange rate | -$0 | |||
| Change in cash and equivalents | -$0.82 | -$2.02 | -$0.43 | -$1.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$17.98 | -$11.27 | -$11.38 | -$16.35 |
| Operating activities | ||||
| Depreciation | $1.15 | $0.93 | $0.63 | $0.74 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.04 | $0.27 | $2.56 | $0.88 |
| Total cash flows from operations | -$3.72 | -$7.28 | -$6.62 | -$14.39 |
| Investing activities | ||||
| Capital expenditures | -$1.73 | -$0.4 | -$0.09 | -$0.02 |
| Investments | ||||
| Total cash flows from investing | -$1.73 | -$0.4 | -$0.09 | -$0.02 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.86 | $4.58 | $6.83 | $10.84 |
| Net borrowings | $4.9 | |||
| Total cash flows from financing | $3.28 | $4.59 | $6.83 | $17.42 |
| Effect of exchange rate | -$0 | -$0.01 | -$0 | |
| Change in cash and equivalents | -$2.18 | -$3.1 | $0.12 | $3 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $9.61M |
|---|---|
| EBITDA | -$5.95M |
| EBIT | -$7.16M |
| Net Income | -$14.74M |
| Revenue Q/Q | 6.42% |
| Revenue Y/Y | -7.53% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -107.53% |
| ROE | -762.31% |
| Debt/Equity | -8.89 |
|---|---|
| Net debt/EBITDA | -1.68 |
| Current ratio | 0.52 |
| Quick ratio | 0.37 |